Clinical trial
Phase IV Prospective, Multi-Center, Randomized, Single-Blind, Active and Standard Care-Controlled Study of DermaPure™ in Patients With "Hard to Heal" Chronic, Neuropathic Diabetic Foot Ulcers With Crossover Design for Standard Care Arm
NCT02081352 is registered in ClinicalTrials.gov with TRx Wound Care Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Prospective, Multi-Center, Randomized, Single-Blind, Active and Standard Care-Controlled Study of DermaPure™ in Patients With "Hard to Heal" Chronic, Neuropathic Diabetic Foot Ulcers With Crossover Design for Standard Care Arm
- Lead sponsor
- TRx Wound Care Limited
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- February 28, 2017
- Enrollment
- 50 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcers